← Back to Search

Digital Health Interventions for COVID-19

N/A

Waitlist Available

Led By Guilherme Del Fiol, MD PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Speak English or Spanish

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 1

Awards & highlights

Study Summary

This trial will increase access to COVID-19 testing and vaccination among underserved populations in Utah using PHM interventions and available technology.

Who is the study for?

This trial is for adults who are current patients at participating community health centers, own a working cellphone, and speak English or Spanish. Their phone number must be listed in the clinic's electronic medical record. Minors cannot participate.Check my eligibility

What is being tested?

SCALE-UP Utah II aims to improve COVID-19 testing among underserved groups using technology like cell phones. It compares patient navigation services and text messaging with conversational agents to see which is more effective.See study design

What are the potential side effects?

Since this study involves communication methods rather than medications, there are no direct medical side effects. However, participants may experience an increase in phone notifications or messages.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Testing

Secondary outcome measures

Vaccines

Reach-Accept Testing

Reach-Engage Testing

+2 more

Trial Design

4Treatment groups

Active Control

Group I: Conversational Agent (CA)+ No Patient NavigationActive Control1 Intervention

Automated, scripted and interactive conversational agent used to mimic human interaction to: 1) elicit specific hesitancy factors and barriers to testing; 2) provide tailored information to address each individual's hesitancy factors and barriers to testing; and 3) offer access to at-home rapid test kits. Patients will not receive patient navigation.

Group II: Conversational Agent (CA) + Request PN (RPN)Active Control2 Interventions

Group III: Text Messaging (TM) + No Patient NavigationActive Control1 Intervention

Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed. Patients will not receive patient navigation.

Group IV: Text Message (TM) + Request (RPN)Active Control2 Interventions

Bidirectional text messaging with a one-touch response to connect patients to vaccination or mailed at-home rapid test kits for use as needed. RPN will provide patients the opportunity to reply PERSON (for connection to a PN) in response to a TM offering connection to testing and/or vaccination.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,098 Previous Clinical Trials

1,736,561 Total Patients Enrolled

14 Trials studying COVID-19

438,577 Patients Enrolled for COVID-19

Utah Department of HealthOTHER

6 Previous Clinical Trials

438,052 Total Patients Enrolled

4 Trials studying COVID-19

263,945 Patients Enrolled for COVID-19

Association for Utah Community HealthOTHER

3 Previous Clinical Trials

262,395 Total Patients Enrolled

3 Trials studying COVID-19

262,395 Patients Enrolled for COVID-19

Media Library

Conversational Agent (CA)+ No Patient Navigation Clinical Trial Eligibility Overview. Trial Name: NCT05533359 — N/A

COVID-19 Research Study Groups: Conversational Agent (CA)+ No Patient Navigation, Conversational Agent (CA) + Request PN (RPN), Text Messaging (TM) + No Patient Navigation, Text Message (TM) + Request (RPN)

COVID-19 Clinical Trial 2023: Conversational Agent (CA)+ No Patient Navigation Highlights & Side Effects. Trial Name: NCT05533359 — N/A

Conversational Agent (CA)+ No Patient Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05533359 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining spots available for the trial?

"This clinical trial is currently seeking participants, with records of its posting and last update dates being available on clinicaltrials.gov. The study was originally posted to the site on 15th January 2023 and the most recent updates occurred 8th May 2023."

Answered by AI

Could you provide an estimation of the number of participants who have agreed to join this experiment?

"Affirmative, data posted to clinicaltrials.gov indicates that the trial is actively seeking participants and was initially posted on 15 January 2023 with a subsequent update dated 8 May 2023. The study necessitates 112479 individuals at one site for enrollment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study

Guilherme Del Fiol 2023. "SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05533359.

All > Covid 19